Navigation Links
PRA SPEAKING EVENT: Phase I Studies with Hepatitis C Compounds in Healthy Volunteers and Patients: Views from Inside
Date:4/8/2009

RALEIGH, N.C., April 8 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces Dr. Andre van Vliet, Vice President of Medical Affairs - Early Development Services (EDS), will host an audio conference on the development of New Chemical Entities (NCEs) in the treatment of hepatitis C. This interactive session will take place on April 14, 2009 at 11:30 am (ET). Drawing on his 19 years of experience in this field, Dr. van Vliet will provide an inside look at opportunities and obstacles when developing a hepatitis C compound including critical steps to optimize the success potential of an NCE as well as pitfalls and obstacles.

Dr. Andre van Vliet is a Board Certified internist, with expertise and training in oncology and clinical Pharmacology. His published materials include a recent article for the American Gastroenterological Association Institute on hepatitis C. Since 1995, he has supervised all aspects of Phase I and IIa drug research for PRA's EDS group.

With 228 beds in Europe and the U.S., and an innovative Phase I model that brings the center to the patients in Central/Eastern Europe, PRA's EDS group provides comprehensive services for Phase I and Phase IIa studies. In the Netherlands, PRA EDS initiated the "Dutch Hepatitis Research Initiative." In this unique research collaboration, PRA EDS collaborates with the Amsterdam Medical Centre and the Rotterdam Erasmus Medical Centre. In PRA's Product Registration group (Phase II and III), over a third of its project management and clinical operations employees are experienced in infectious diseases clinical research.

The deadline for registration is Monday, April 13, 2009. To learn more about the audio conference, click '/>"/>

SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PRA International Speaking Event: Beyond Global Feasibility
2. PRA International Speaking Event: Rational Drug Design and Development in Infectious Diseases
3. Folic acid survey of Spanish-speaking women finds most are missing benefits, March of Dimes says
4. First Nationwide Folic Acid Survey of Spanish-Speaking Women Finds Most Are Missing Benefits, March of Dimes Says
5. Newport Introduces More Resources for Spanish Speaking Plan Participants
6. Response rates to antidepressants differ among English- and Spanish-speaking Hispanics
7. When it comes to abstinence teens, adults arent speaking the same language
8. Children in non-English-speaking households face many health disparities, researcher concludes
9. Medpace Director of Clinical Pharmacology, Jim Wei, MD, PhD, Embarks on a Regulatory Policy Speaking Tour in China in May
10. Speaking of Womens Health Gives the Gift of Knowledge and Good Health This Mothers Day
11. Revolabs xTag(TM) Wireless Microphone Now Offered as a Total Solution With Dragon(R) NaturallySpeaking(R) Medical Software from Nuance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... from more emotional and behavioral difficulties when compared to ... the most when a parent is deployed overseas, according ... that having a parent deployed for a longer period ... struggled with emotional problems were important factors associated with ... study published online by the journal Pediatrics . ...
(Date:12/6/2009)... Consumers advised to avoid oysters harvested from San Antonio ... -- The U.S. Food and Drug Administration is advising ... Antonio Bay on or after Nov. 16 due to ... consumed oysters harvested from this area, which is located ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ,, The FDA, along with ...
(Date:12/6/2009)... study by researchers from the Medical College of Wisconsin, ... for pain and other sickle cell disease complications in ... both providers and patients were also identified. The ... professor of pediatrics at the Medical College and Children,s ... be presented at the American Society of Hematology meeting ...
(Date:12/6/2009)... www.sleeping-with-a-sleeping-disorder.com is asking people ,who have ... aids from around the world to donate their ... submissions will be compiled in an ebook titled ... be sold from the website in early January ... proceeds ,from sales of the E-book to three ...
(Date:12/5/2009)... Dec. 5 ,, What: Cuts for ... difference in the fight against cancer and other terminal illnesses ... be donated to St. Jude Children,s Research Hospital. Guests will ... a delectable and savory Vietnamese restaurant in Falls Church for ...
Breaking Medicine News(10 mins):Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 2Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 3Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2
... on findings of a recent study researchers say people ... also is infectious diseases // . ,Previous studies ... of tuberculosis on planes. Results suggest sitting within two ... longer than eight hours places passengers at risk of ...
... in the country of Angola, people had been warned not to ... ,The number of people who are affected by the virus ... Health Organization, the two third of those affected by the virus ... in 1967 is said to cause nausea, stomachaches, vomiting and diarrhea. ...
... that causes a number of blood disorders ahs been found ... to a new study. ,Researchers were able to develop ... in most patients with myeloproliferative blood disorders. These disorders are ... hemorrhage or acute myeloid leukemia. ,A gene called JAK2 ...
... the standard test to detect dementia so that it ... early. The test called National Institute //of Ageing's ... list (CWL) needs only ten minutes to administer. ... dementia as these stages often go undetected. They used ...
... new study has found out that depression has to be ... // used to treat the same. The study was conducted ... first glance, results showed both the newer and older classes ... within the first month of being prescribed.The older class of ...
... new study shows how the risk of death and heart ... It was found that doubling the usual dose of an ... ,Angioplasty is a procedure in which a balloon-tipped catheter is ... plaque in the artery and unblock the vessel. A small ...
Other Medicine News:
(Date:12/6/2009)... SEOUL, Korea, Dec. 6 RNL Bio ... company specialized in adult stem cell therapeutics announced ... Multiple Sclerosis improved tremendously after receiving stem cell ... an autoimmune disease that affects the central nervous ... Sclerosis is a disease in which the nerves ...
(Date:12/4/2009)... INDIANAPOLIS, Dec. 4 The U.S. Food ... tablet form as an option for the treatment of ... I disorder in adolescents aged 13-17 years old. ... take into consideration the increased potential for weight gain ...
(Date:12/4/2009)... Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, ... chapter of the American Red Cross are hard at ... that they endure that could potentially put Philadelphia,s blood ... on strike and set up a picket line yesterday ...
Breaking Medicine Technology:Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2AMA Supports Health System Reform Alternatives Consistent With Principles of Pluralism Freedom of Choice Freedom of Practice and Universal Access fo 49246 1AMA Supports Health System Reform Alternatives Consistent With Principles of Pluralism Freedom of Choice Freedom of Practice and Universal Access fo 49246 2Pharmaceutical Institute Launches New E Course Focused on Health Policy 12677 1Pharmaceutical Institute Launches New E Course Focused on Health Policy 12677 2Pharmaceutical Institute Launches New E Course Focused on Health Policy 12677 3Structures from the human immune systems oldest branch shed light on a range of diseases 49239 1Structures from the human immune systems oldest branch shed light on a range of diseases 49239 2Structures from the human immune systems oldest branch shed light on a range of diseases 49239 3
... Potential Benefit of Unique OROS(R),Formulation, SAN DIEGO, ... abuse,remains an ongoing concern for parents and ... Hyperactivity Disorder,(ADHD). Data presented on Tuesday at ... Association highlighted findings that,long-acting OROS(R) methylphenidate had ...
... 22, 2007,/PRNewswire-FirstCall/ -- Palatin Technologies, Inc. and ... Study 16 and,Study 17 of the Phase ... with erectile dysfunction (ED) were presented,yesterday at ... 2007) held in Anaheim, CA. New positive ...
Other Medicine Technology:New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 2New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 3New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 4New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 5Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 2Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 3Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 4Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 5Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 6Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 7
... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
... provide a broad selection of ... a wide variety of ophthalmic ... is packaged sterile, complete with ... switch in the "off " ...
Medicine Products: